Login / Signup

Cost-Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation.

Hyunmee KimHyeongsoo KimSeong-Kyung ChoJin-Bae KimBoyoung JoungChang-Soo Kim
Published in: Korean circulation journal (2018)
Patients who had been treated with rivaroxaban may be a cost-effective alternative to warfarin for stroke prevention in Korean patients with AF.
Keyphrases
  • atrial fibrillation
  • oral anticoagulants
  • direct oral anticoagulants
  • left atrial
  • catheter ablation
  • left atrial appendage
  • heart failure
  • percutaneous coronary intervention
  • pulmonary embolism
  • cerebral ischemia